International Journal of Molecular Sciences (Apr 2019)

SUMOylation in Glioblastoma: A Novel Therapeutic Target

  • Brandon M. Fox,
  • Andrew Janssen,
  • Dagoberto Estevez-Ordonez,
  • Florian Gessler,
  • Nunzio Vicario,
  • Gustavo Chagoya,
  • Galal Elsayed,
  • Houman Sotoudeh,
  • William Stetler,
  • Gregory K. Friedman,
  • Joshua D. Bernstock

DOI
https://doi.org/10.3390/ijms20081853
Journal volume & issue
Vol. 20, no. 8
p. 1853

Abstract

Read online

Protein SUMOylation is a dynamic post-translational modification which is involved in a diverse set of physiologic processes throughout the cell. Of note, SUMOylation also plays a role in the pathobiology of a myriad of cancers, one of which is glioblastoma (GBM). Accordingly, herein, we review core aspects of SUMOylation as it relates to GBM and in so doing highlight putative methods/modalities capable of therapeutically engaging the pathway for treatment of this deadly neoplasm.

Keywords